1. Home
  2. VCYT
  3. VCYT News

Latest Veracyte Inc. (VCYT) News on June 21, 2025

Veracyte (NASDAQ:VCYT) shareholders have earned a 19% return over the last year
VCYT

Simply Wall St.

a day ago

Veracyte (NASDAQ:VCYT) shareholders have earned a 19% return over the last year

Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound?
VCYT

Zacks

15 days ago

Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound?

Veracyte, Inc. (VCYT) Presents Breakthrough Genomic Data to Predict Cancer Therapy Response at ASCO
VCYT

Insider Monkey

24 days ago

Veracyte, Inc. (VCYT) Presents Breakthrough Genomic Data to Predict Cancer Therapy Response at ASCO

Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research
VCYT

Business Wire

24 days ago

Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research

Veracyte to Participate in Upcoming Investor Conferences
VCYT

Business Wire

a month ago

Veracyte to Participate in Upcoming Investor Conferences

Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally?
VCYT

Zacks

a month ago

Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally?

Veracyte, Inc. Just Recorded A 260% EPS Beat: Here's What Analysts Are Forecasting Next
VCYT

Simply Wall St.

a month ago

Veracyte, Inc. Just Recorded A 260% EPS Beat: Here's What Analysts Are Forecasting Next

Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up
VCYT

Zacks

a month ago

Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up

Veracyte First Quarter 2025 Earnings: Beats Expectations
VCYT

Simply Wall St.

a month ago

Veracyte First Quarter 2025 Earnings: Beats Expectations

What Makes Veracyte (VCYT) a New Buy Stock
VCYT

Zacks

a month ago

What Makes Veracyte (VCYT) a New Buy Stock

VCYT

MT Newswires

a month ago

UBS Cuts Price Target on Veracyte to $42 From $49, Keeps Buy Rating

Veracyte Inc (VCYT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions
VCYT

GuruFocus.com

a month ago

Veracyte Inc (VCYT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions

Veracyte (VCYT) Q1 Earnings and Revenues Beat Estimates
VCYT

Zacks

a month ago

Veracyte (VCYT) Q1 Earnings and Revenues Beat Estimates

VCYT

Associated Press Finance

a month ago

Veracyte: Q1 Earnings Snapshot

Veracyte Announces First Quarter 2025 Financial Results
VCYT

Business Wire

a month ago

Veracyte Announces First Quarter 2025 Financial Results

Veracyte Stock Earns Relative Strength Rating Upgrade
VCYT

Investor's Business Daily

2 months ago

Veracyte Stock Earns Relative Strength Rating Upgrade

Ekso Bionics (EKSO) Reports Q1 Loss, Misses Revenue Estimates
VCYT

Zacks

2 months ago

Ekso Bionics (EKSO) Reports Q1 Loss, Misses Revenue Estimates

Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer
VCYT

Business Wire

2 months ago

Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer

Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting
VCYT

Business Wire

2 months ago

Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting

Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
VCYT

Business Wire

2 months ago

Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
VCYT

Investor's Business Daily

2 months ago

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

Should You Continue to Hold Veracyte Stock in Your Portfolio?
VCYT

Zacks

2 months ago

Should You Continue to Hold Veracyte Stock in Your Portfolio?

Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025
VCYT

Business Wire

2 months ago

Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025

Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term
VCYT

Zacks

2 months ago

Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term

Here's Why Veracyte (VCYT) is a Strong Growth Stock
VCYT

Zacks

2 months ago

Here's Why Veracyte (VCYT) is a Strong Growth Stock

Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain?
VCYT

Zacks

2 months ago

Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain?

Veracyte And 2 More Stocks That Might Be Trading Below Their Estimated Value
VCYT

Simply Wall St.

2 months ago

Veracyte And 2 More Stocks That Might Be Trading Below Their Estimated Value

Veracyte (VCYT) Just Overtook the 20-Day Moving Average
VCYT

Zacks

2 months ago

Veracyte (VCYT) Just Overtook the 20-Day Moving Average

Strength Seen in Veracyte (VCYT): Can Its 13.0% Jump Turn into More Strength?
VCYT

Zacks

2 months ago

Strength Seen in Veracyte (VCYT): Can Its 13.0% Jump Turn into More Strength?

Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago
VCYT

Zacks

2 months ago

Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago

Veracyte (VCYT) Introduces AI-Powered Cancer Detection – Faster and More Accurate Than Ever!
VCYT

Insider Monkey

3 months ago

Veracyte (VCYT) Introduces AI-Powered Cancer Detection – Faster and More Accurate Than Ever!

Veracyte (VCYT) Up 0.7% Since Last Earnings Report: Can It Continue?
VCYT

Zacks

3 months ago

Veracyte (VCYT) Up 0.7% Since Last Earnings Report: Can It Continue?

Wall Street Analysts Believe Veracyte (VCYT) Could Rally 35.05%: Here's is How to Trade
VCYT

Zacks

3 months ago

Wall Street Analysts Believe Veracyte (VCYT) Could Rally 35.05%: Here's is How to Trade

VCYT

MT Newswires

3 months ago

Veracyte Cancer Diagnostic Platform Shows Higher Specificity Than Blood Tests

New Data Demonstrate Accuracy of Veracyte’s Whole-Genome Sequencing-Based MRD Testing Platform for Muscle-Invasive Bladder Cancer
VCYT

Business Wire

3 months ago

New Data Demonstrate Accuracy of Veracyte’s Whole-Genome Sequencing-Based MRD Testing Platform for Muscle-Invasive Bladder Cancer

US High Growth Tech Stocks With Promising Potential
VCYT

Simply Wall St.

3 months ago

US High Growth Tech Stocks With Promising Potential

GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?
VCYT

Zacks

3 months ago

GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?

VCYT

MT Newswires

3 months ago

Craig-Hallum Initiates Veracyte at Buy With $45 Price Target

Veracyte Announces Eight Abstracts Highlighting Performance and Clinical Utility of Its Decipher and MRD Tests in Urologic Cancers To Be Presented at EAU25
VCYT

Business Wire

3 months ago

Veracyte Announces Eight Abstracts Highlighting Performance and Clinical Utility of Its Decipher and MRD Tests in Urologic Cancers To Be Presented at EAU25

Veracyte Stock Surges 45.6% in a Year: What's Driving the Rally?
VCYT

Zacks

3 months ago

Veracyte Stock Surges 45.6% in a Year: What's Driving the Rally?

Veracyte (VCYT) Surged on Reporting Strong Earnings
VCYT

Insider Monkey

3 months ago

Veracyte (VCYT) Surged on Reporting Strong Earnings

Veracyte Full Year 2024 Earnings: EPS Misses Expectations
VCYT

Simply Wall St.

4 months ago

Veracyte Full Year 2024 Earnings: EPS Misses Expectations

Veracyte's (NASDAQ:VCYT) Performance Is Even Better Than Its Earnings Suggest
VCYT

Simply Wall St.

4 months ago

Veracyte's (NASDAQ:VCYT) Performance Is Even Better Than Its Earnings Suggest

Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom
VCYT

Zacks

4 months ago

Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom

VCYT

Thomson Reuters StreetEvents

4 months ago

Q4 2024 Veracyte Inc Earnings Call

VCYT

MT Newswires

4 months ago

UBS Adjusts Veracyte Price Target to $49 From $46, Maintains Buy Rating

Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat
VCYT

Zacks

4 months ago

Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat

Veracyte Inc (VCYT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
VCYT

GuruFocus.com

4 months ago

Veracyte Inc (VCYT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

VCYT

MT Newswires

4 months ago

Veracyte Q4 Non-GAAP Earnings, Revenue Rise; Shares Fall After-Hours

Veracyte (VCYT) Q4 Earnings and Revenues Beat Estimates
VCYT

Zacks

4 months ago

Veracyte (VCYT) Q4 Earnings and Revenues Beat Estimates

VCYT

Associated Press Finance

4 months ago

Veracyte: Q4 Earnings Snapshot

Veracyte Announces Fourth Quarter and Full Year 2024 Financial Results
VCYT

Business Wire

4 months ago

Veracyte Announces Fourth Quarter and Full Year 2024 Financial Results

What To Expect From Veracyte Inc (VCYT) Q4 2024 Earnings
VCYT

GuruFocus.com

4 months ago

What To Expect From Veracyte Inc (VCYT) Q4 2024 Earnings

Is Veracyte Stock a Good Addition to Your Portfolio Right Now?
VCYT

Zacks

4 months ago

Is Veracyte Stock a Good Addition to Your Portfolio Right Now?

High Growth Tech Stocks To Watch In February 2025
VCYT

Simply Wall St.

4 months ago

High Growth Tech Stocks To Watch In February 2025

Veracyte to Participate in Upcoming Investor Conferences
VCYT

Business Wire

4 months ago

Veracyte to Participate in Upcoming Investor Conferences

Schrodinger Stock Scores IBD Rating Upgrade
VCYT

Investor's Business Daily

4 months ago

Schrodinger Stock Scores IBD Rating Upgrade

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research
VCYT

Business Wire

4 months ago

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research

Best Momentum Stocks to Buy for February 13th
VCYT

Zacks

4 months ago

Best Momentum Stocks to Buy for February 13th

Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU Symposium
VCYT

Business Wire

4 months ago

Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU Symposium

New Study Shows Veracyte’s Decipher Bladder Test Predicts Disease Upstaging in Patients with Bladder Cancer
VCYT

Business Wire

5 months ago

New Study Shows Veracyte’s Decipher Bladder Test Predicts Disease Upstaging in Patients with Bladder Cancer

Veracyte to Release Fourth Quarter and Full-Year 2024 Financial Results on February 24, 2025
VCYT

Business Wire

5 months ago

Veracyte to Release Fourth Quarter and Full-Year 2024 Financial Results on February 24, 2025

VCYT

Zacks

5 months ago

Brian's Big Idea: Healthcare Stocks

VCYT

MT Newswires

5 months ago

Needham Boosts Price Target on Veracyte to $51 From $44, Keeps Buy Rating

3 US Stocks Estimated To Be Undervalued By Up To 49.9% Presenting An Opportunity
VCYT

Simply Wall St.

5 months ago

3 US Stocks Estimated To Be Undervalued By Up To 49.9% Presenting An Opportunity

Exploring High Growth Tech Stocks in January 2025
VCYT

Simply Wall St.

5 months ago

Exploring High Growth Tech Stocks in January 2025

GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues
VCYT

Zacks

5 months ago

GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues

Veracyte, Inc. (NASDAQ:VCYT) Has Found A Path To Profitability
VCYT

Simply Wall St.

5 months ago

Veracyte, Inc. (NASDAQ:VCYT) Has Found A Path To Profitability

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
VCYT

Zacks

5 months ago

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks

Veracyte Gains 44% in a Year: What's Driving the Stock?
VCYT

Zacks

5 months ago

Veracyte Gains 44% in a Year: What's Driving the Stock?

Macroeconomic Woes, FX Headwind Drag NEOG Stock Down
VCYT

Zacks

6 months ago

Macroeconomic Woes, FX Headwind Drag NEOG Stock Down

Phibro Animal Health Gains 83% in a Year: What's Driving the Stock?
VCYT

Zacks

6 months ago

Phibro Animal Health Gains 83% in a Year: What's Driving the Stock?

Should You Retain Labcorp Stock in Your Portfolio Right Now?
VCYT

Zacks

6 months ago

Should You Retain Labcorp Stock in Your Portfolio Right Now?

Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now
VCYT

Zacks

6 months ago

Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now

The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories
VCYT

Zacks

6 months ago

The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories

Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?
VCYT

Zacks

6 months ago

Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?

4 Healthcare Technology Innovators to Invest in Before the New Year
VCYT

Zacks

6 months ago

4 Healthcare Technology Innovators to Invest in Before the New Year

The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte
VCYT

Zacks

6 months ago

The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte

3 Medical Instruments Industry Stocks to Buy on the GenAI Wave
VCYT

Zacks

6 months ago

3 Medical Instruments Industry Stocks to Buy on the GenAI Wave

Exploring Three High Growth Tech Stocks In The United States
VCYT

Simply Wall St.

6 months ago

Exploring Three High Growth Tech Stocks In The United States

US Exchange: 3 Stocks That May Be Trading Below Fair Value
VCYT

Simply Wall St.

6 months ago

US Exchange: 3 Stocks That May Be Trading Below Fair Value

Why Veracyte, With 55% Growth In 2024, Is An Outlier In Cancer Diagnostics
VCYT

Investor's Business Daily

6 months ago

Why Veracyte, With 55% Growth In 2024, Is An Outlier In Cancer Diagnostics

Veracyte (VCYT) Shares Rebounded in Q3
VCYT

Insider Monkey

6 months ago

Veracyte (VCYT) Shares Rebounded in Q3

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen
VCYT

Zacks

6 months ago

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen

Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68%
VCYT

Simply Wall St.

6 months ago

Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68%

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
VCYT

Zacks

6 months ago

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now
VCYT

Zacks

6 months ago

If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now

5 Medical Device Stocks That Survived the 2024 Market Volatility
VCYT

Zacks

6 months ago

5 Medical Device Stocks That Survived the 2024 Market Volatility

Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines
VCYT

Business Wire

7 months ago

Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines

VCYT

MT Newswires

7 months ago

Goldman Sachs Downgrades Veracyte to Neutral From Buy, Trims Price Target to $37 From $38

Four Reasons To Watch This AI Play. A Fresh Breakout Is Just One.
VCYT

Investor's Business Daily

7 months ago

Four Reasons To Watch This AI Play. A Fresh Breakout Is Just One.

VCYT

MT Newswires

7 months ago

Morgan Stanley Lifts Price Target on Veracyte to $28 From $26, Keeps Underweight Rating

VCYT

MT Newswires

7 months ago

Wolfe Research Initiates Veracyte at Outperform With $50 Price Target

VCYT

MT Newswires

7 months ago

Veracyte Insider Sold Shares Worth $585,663, According to a Recent SEC Filing

High Growth Tech Stocks To Watch In November 2024
VCYT

Simply Wall St.

7 months ago

High Growth Tech Stocks To Watch In November 2024

US Stocks Possibly Trading Below Fair Value Estimates In November 2024
VCYT

Simply Wall St.

7 months ago

US Stocks Possibly Trading Below Fair Value Estimates In November 2024

Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next
VCYT

Simply Wall St.

7 months ago

Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next

Veracyte Third Quarter 2024 Earnings: Beats Expectations
VCYT

Simply Wall St.

7 months ago

Veracyte Third Quarter 2024 Earnings: Beats Expectations

VCYT

MT Newswires

7 months ago

UBS Adjusts Price Target on Veracyte to $46 From $43, Maintains Buy Rating

Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised
VCYT

Zacks

7 months ago

Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised

Share on Social Networks: